Friday Dec 6
4 Fairy Tales That Questcor Longs Believe
I laid out my argument for going short on Questcor Pharmaceuticals in late October of this year, citing insider selling and questionable items that had been pointed out by Citron Research prior to my article.
Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
The replay will be available for approximately 90 days after the event. Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.
Polycom, Inc. (NASDAQ:PLCM) and Questcor Pharmaceuticals, Inc....
Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Polycom, Inc. and Questcor Pharmaceuticals, Inc. .
Questcor Pharmaceuticals' Management presents at the Goldman Sachs US ...
Hi everyone! Good morning. Thank you for being here today, third day. So thank you for attending Questcor's presentation this morning.
Insider Selling: Broadwood Partners Lp Unloads 500,000 Shares of...
Questcor Pharmaceuticals Director Broadwood Partners Lp sold 500,000 shares of Questcor Pharmaceuticals stock in a transaction that occurred on Wednesday, November 13th.
Questcor Adds G. Kelly Martin to Board of Directors
Questcor Pharmaceuticals, Inc. today announced the addition of G. Kelly Martin, President and Chief Executive Officer of Elan Corporation, plc, to Questcor's Board of Directors, bringing the number of directors to eight, seven of whom are independent.